De-Risking Bio-therapeutics for Possible Drug Interactions Using Cryopreserved Human Hepatocytes

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|7|923-929

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.7, 2012-09, pp. : 923-929

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

De-risking Scale-up of a High Shear Wet Granulation Process Using Latent Variable Modeling and Near-Infrared Spectroscopy

By Muteki Koji  

Journal of Pharmaceutical Innovation, Vol. 6, Iss. 3, 2011-09 ,pp. : 142-156

Springer Publishing Company

Access to resources Recommend Favorite

Interactions of Polyphenols with the P450 System: Possible Implications on Human Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 2, 2008-02 ,pp. : 97-106

Bentham Science Publishers

Access to resources Recommend Favorite

Developability assessment as an early de-risking tool for biopharmaceutical development

By Zurdo Jesús  

Pharmaceutical Bioprocessing, Vol. 1, Iss. 1, 2013-04 ,pp. : 29-50

Future Science

Access to resources Recommend Favorite

Editorial [Hot Topic: De-risking the Discovery and Development of New Drugs from Bench to Clinic (Guest Editor: Sergey Ilyin)]

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1031-1031

Bentham Science Publishers

Access to resources Recommend Favorite

Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism

By  

Current Drug Metabolism, Vol. 4, Iss. 4, 2003-08 ,pp. : 292-312

Bentham Science Publishers

Access to resources Recommend Favorite